David Stein, MD
Psychiatry · Honolulu, HINPI 1740386341
Payments from drug & device makers
Across 1,425 payments — averaging $130.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$68K
- Alkermes, Inc.$67K
- Otsuka America Pharmaceutical, Inc.$15K
- E.r. Squibb & Sons, L.L.C.$15K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- Sunovion Pharmaceuticals Inc.$3K
- plus $14K from 16 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 233 | $67,767 |
| Alkermes, Inc. | 207 | $66,801 |
| Otsuka America Pharmaceutical, Inc. | 62 | $15,110 |
| E.r. Squibb & Sons, L.L.C. | 44 | $14,830 |
| Takeda Pharmaceuticals U.S.A., Inc. | 192 | $3,915 |
| Sunovion Pharmaceuticals Inc. | 171 | $3,251 |
| Neurocrine Biosciences, Inc. | 77 | $3,243 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 133 | $3,173 |
| Teva Pharmaceuticals USA, Inc. | 103 | $2,713 |
| Johnson & Johnson | 53 | $1,500 |
| Lundbeck LLC | 70 | $993 |
| Axsome Therapeutics, Inc. | 16 | $752 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $443 |
| Vanda Pharmaceuticals Inc. | 19 | $416 |
| Janssen Scientific Affairs, LLC | 3 | $330 |
| Eisai Inc. | 7 | $224 |
| Idorsia Pharmaceuticals US Inc | 4 | $189 |
| Corium, LLC | 13 | $184 |
| Merck | 7 | $121 |
| Indivior Inc. | 4 | $93 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
How this compares
$186,088 in reported general payments places this provider in the 95th percentile of 183 psychiatry providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Honolulu
- Denis Mee-LeeHonolulu$547K
- Gregory YuenHonolulu$6K
- Raymond DavidsonHonolulu$6K
- Helen Blaisdell-BrennanHonolulu$6K
- Glorifin BelmonteHonolulu$5K
- Brett LuHonolulu$5K
- Donna McBrien SliwowskiHonolulu$4K
- Alan BuffensteinHonolulu$3K
- Nancy LuckieHonolulu$3K
- Angela KingHonolulu$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.